Hyperbaric oxygen treatment time for cyclophosphamide induced cystitis in rats

Undersea and Hyperbaric Medicine

Volumn 31, Issue 2, 2004, Pages 211-216

  Oztas, E ^a   Korkmaz, A ^a   Oter, S ^a   Topal, T ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE;

ANIMAL; ARTICLE; BLADDER; CHEMICALLY INDUCED DISORDER; CYSTITIS; DRUG EFFECT; HYPERBARIC OXYGEN; MALE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; CYSTITIS; HYPERBARIC OXYGENATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; URINARY BLADDER;

EID: 4544299704     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Levine AL, Richie PJ. Urological complications of cyclophosphamide. J Urol 1989; 141:1063-1069.
2. Philips FS, Sternberg SS, Cronin AP, Vidal PM. Cyclophosphamide and urinary bladder toxicity. Cancer Res 1961; 21:1557-1562.
3. West N J. Prevention and treatment of hemorrhagic cystitis. Pharmacotherapy 1997; 17(4):696-706.
4. Brock N, Pohl J, Stekar J. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. I. Experimental studies on the urotoxicity of alkylating compounds. Eur J Cancer 1981; 17(6):595-607.
5. Schellpfeffer MC, Gerber SG. The use of hyperbaric oxygen in urology. J Urol 1999; 162:647-654.
6. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb. Med. 2002 Spring; 29(1):4-30.
7. Isao K, Kuwata Y, Kakehi Y. Hyperbaric oxygen therapy for Wegener's granulomatosis with cyclophosphamide-induced hemorrhagic cystitis. Int J Urol 2002; 9:470-472.
8. 2 treatments in cyclophosphamide-induced hemorrhagic cystitis. J Urol 1997; 158(6):2296-2299.
9. Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs. J Urol 2001; 166(3):1119-1123.
10. Oztas E, Kilic A, Ozyurt M, Korkmaz A, Basustaoglu A. Effect of hyperbaric oxygen and penicillin in a murine model of streptococcal myositis. Undersea Hyperb Med 2001 Fall; 28(4):181-186.
11. Yamashita M, Yamashita M. Hyperbaric oxygen treatment attenuates cytokine induction after massive hemorrhage. Am J Physiol Endocrinol Metab 2000; 278(5):E811-816.
12. Buras J. Basic mechanisms of hyperbaric oxygen in the treatment of ischemia-reperfusion injury. Int Anesthesiol Clin 2000; 38(1):91-109.
13. Gomes TN, Santos CC, Souza-Filho MV, Cunha FQ, Ribeiro RA. Participation of TNF-α and IL-1 in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Braz J Med Biol Res 1995; 28(10):1103-1108.
14. Souza-Fiho MV, Lima MV, Pompeu MM, Ballejo G, Cunha FQ, Ribeiro RA. Involvement of nitric oxide in the pathogenesis of cyclophosphamide-induced hemorrhagic cystitis. Am J Pathol 1997; 150:247-256.
15. Ribeiro RA, Feritas HC, Campos MC, et al. Tumor necrosis factor-α and interleukin-1β mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol 2002; 167(5):2229-2234.
16. Korkmaz A, Oter S, Deveci S, et al. Involvement of nitric oxide and hyperbaric oxygenation in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol 2003; 170(6):2498-2502.
17. Malley SE, Vizzard MA. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis. Physiol Genomics 2002; 9(1):5-13.
18. Zamboni WA, Roth AC, Russell RC, Graham B, Suchy H, Kucan JO. Morphologic analysis of the microcirculation during reperfusion of ischemic skeletal muscle and the effect of hyperbaric oxygen. Plastic Reconstr Surg 1993; 91(6):1110-1123.
19. Buras JA, Stahl GL, Svoboda KKH, Reenstra WR. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol 2000; 278(2):C292-302.
20. Mathews R, Rajan N, Josefson L, Camporesi E, Makhuli Z. Hyperbaric oxygen therapy for radiation induced hemorrhagic cystitis. J Urol 1999; 161(2):435-437.
21. Hader JE, Marzella L, Myers RA, Jacobs SC, and Naslund MJ.: Hyperbaric oxygen treatment for experimental cyclophosphamide-induced hemorrhagic cystitis. J Urol 1993; 149(6):1617-1622.
22. Koss LG. A light and electron microscopic study of the effects of a single dose of cyclophosphamide on various organs in the rat. Lab Invest 1967; 16:44-47.
23. Lopez AE, Rodriguez S, Flores I. Management of ischemic hemorrhagic cystitis with hyperbaric oxygen therapy. Undersea Hyperb. Med. 2001 Spring; 28(1):35-36.
24. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990; 169:519-524.
25. Bevers RFM, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis, Lancet 1995; 346:803-805.
26. T.C.S. Woo, D. Joseph, H. Oxer, Hyperbaric oxygen treatment for radiation proctitis. Int J Radiat Oncol Biol Phys 1997; 38:619-622.
27. Sminia P, VanDer Kleij AJ, Carl UM, Feldmeier JJ, Hartmann KA. Prophylactic hyperbaric oxygen treatment and rat spinal cord re-irradiation. Cancer Lett 2003; 191(1):59-65.